Power Law company profile

10X Genomics

Biotech & Life Sciences · Pleasanton, United States · Founded 2012 · IPO 2019 Unicorn

Building tools for scientific discovery that reveal and address the true complexities of biology and disease

Valuation

$2.41B

Market cap · May/2026

Revenue

$643M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $10B+ revenueThoroughbred · Power Law outcome

Investors

10 investors on 10X Genomics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 10 investors entered at this stage

Verge Genomics

Venrock

Meritech Capital

Wells Fargo Capital Finance

Shivom

Paladin Capital Group

10X Genomics mafia

Startups founded by 10X Genomics alumni

Former 10X Genomics employees who went on to start their own companies. Sorted by Dealroom signal score.

Alvaro Martinez BarrioSweden

Mahsa VazinUnited States

Signal score78

InfinimmuneEst. 2022

DJdavid jaffeUnited States

Signal score76

Ultima GenomicsEst. 2016

Mark PrattUnited States

Ravi RamenaniUnited States

Book a demo to explore the full alumni network →

Global footprint

Where 10X Genomics has talent and traffic

AI talent share

0.3% of workforce is AI talent
(8 of 2,311 staff)

Core AI20.09%

Other AI60.26%

Non-AI workforce2,30399.65%

Workforce by country

34 countries with
team presence

🇺🇸 United States74.1%

🇸🇬 Singapore5.9%

🇬🇧 United Kingdom3.1%

🇳🇱 Netherlands3%

🇩🇪 Germany2.4%

Top 5 of 34 shown

Web traffic by country

280K monthly visits
across markets

🇺🇸 United States32.5%

🏳️ Korea6.8%

🏳️ Republic of5.2%

🇻🇳 Vietnam4.7%

🇯🇵 Japan4.1%

Top 5 markets shown

Patent intelligence

$219M patent portfolio · 557 active families

Estimated portfolio value

$219M

9.1% of market cap · 28.8× the top peer Sophia Genetics ($8M)

557 active patent families

Where 10X Genomics innovates Molecular biologyBioinformaticsBiological organismBiophysicsAnalyte

Where 10X Genomics concentrates vs peers

Each axis is a top-10 topic across 10X Genomics and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

10X Genomics's 6 investments and acquisitions.

Every disclosed deal where 10X Genomics appeared as a backer or acquirer, 2018–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

6 deals across 10X Genomics's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount

By stageCount

By periodCount

01 · Deployment strategy vs peers

Where 10X Genomics deploys vs peers

Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

Compare against

02 · Portfolio market map

10X Genomics's portfolio, mapped.

Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

Stage

Period

6 of 6 deals

Market sentiment

What the market is saying about 10X Genomics

An AI-synthesized read of the highest-engagement posts about 10X Genomics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See 10X Genomics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles